News 02 Jun 2023 Abiogen Pharma acquires majority stake in EffRx Abiogen, a pharmaceutical firm based in the Italian city of Pisa, has acquired a 97.09 percent stake in EffRx Pharmaceuticals. Since 2014, Abioge...
Spotlight 15 Jun 2023 Access to Ecosystem Switzerland is a global leader in biotech, medtech and pharma. Find out what makes the Swiss life science industry unique and how your life scien...
Medienmitteilungen 08 Mar 2022 Switzerland Global Enterprise und Schweiz Tourismus holen innovative Firmen in die Schweiz Die Schweiz ist als Innovationsstandort prädestiniert für die Entwicklung neuer Geschäftsmodelle mit Zukunftstechnologien. Eine wichtige Rolle sp...
Communiqués de Presse 06 Abr 2022 Switzerland Global Enterprise et Suisse Tourisme invitent des Enterprises d'avant-garde à s'établir en Suisse Berceau de quantité d’innovations, la Suisse est propice au développement de nouveaux modèles d’affaires impliquant les technologies d’avenir. L’...
Press Release 08 Mar 2022 Switzerland Global Enterprise and Switzerland Tourism attract innovative companies to Switzerland As a location for innovation, Switzerland is predestined for the development of new business models with future technologies. The settlement of i...
Comunicati Stampa 10 Mar 2022 Switzerland Global Enterprise e Svizzera Turismo invitano aziende innovative in Svizzera La Svizzera, nel suo ruolo di piazza d’innovazione, è ideale per lo sviluppo di nuovi modelli di business con tecnologie del futuro. Un ruolo imp...
News 17 Nov 2021 Inflamalps takes part in a significant biopharmaceutical research project Biopharmaceutical company Inflamalps has just entered a major Innosuisse project, which aims to discover at least one new class of antimicrobial ...
Report 21 Jul 2021 Key Swiss Circular Economy Features In our current linear economic model the principle of "take-make-waste" dominates. This economic model leads to resource scarcity, waste and ulti...